Lonza Group AG (OTCMKTS:LZAGY) Expected to Post FY2025 Earnings of $1.81 Per Share

Lonza Group AG (OTCMKTS:LZAGY) – Equities researchers at William Blair lifted their FY2025 EPS estimates for Lonza Group in a research note issued to investors on Thursday, July 25th. William Blair analyst M. Smock now forecasts that the company will post earnings per share of $1.81 for the year, up from their previous estimate of $1.75. The consensus estimate for Lonza Group’s current full-year earnings is $1.38 per share.

Separately, Berenberg Bank upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Sunday, June 23rd.

Lonza Group Stock Up 1.0 %

Shares of Lonza Group stock opened at $65.65 on Monday. The firm’s 50-day moving average price is $56.22 and its two-hundred day moving average price is $54.75. The company has a current ratio of 1.77, a quick ratio of 1.20 and a debt-to-equity ratio of 0.27. Lonza Group has a 12-month low of $34.19 and a 12-month high of $66.02.

Lonza Group Cuts Dividend

The company also recently declared a dividend, which was paid on Wednesday, May 29th. Shareholders of record on Thursday, May 16th were issued a dividend of $0.0995 per share. The ex-dividend date was Wednesday, May 15th.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.